4.8 Article

Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses

Saathvik R. Kannan et al.

Summary: The study revealed differences in the mutational profile between Delta and Delta Plus variants, with Delta Plus having more high-prevalence mutations and unique signature mutations. Structural analysis showed that these mutations can weaken the interactions between the virus and antibodies.

JOURNAL OF AUTOIMMUNITY (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

Qianqian Li et al.

Summary: The 501Y.V2 variants of SARS-CoV-2 with multiple mutations are rapidly spreading from South Africa to other countries, showing reduced susceptibility to neutralizing antibodies and potential compromise of monoclonal antibodies and vaccines. Enhanced infectivity in murine ACE2-overexpressing cells suggests the possibility of transmission to mice.
Article Biochemistry & Molecular Biology

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Piyada Supasa et al.

Summary: Research on the UK-dominant variant B.1.1.7 shows that it is harder to neutralize than the parental virus, but widespread escape from antibodies or monoclonal antibodies has not been observed yet.
Article Biochemistry & Molecular Biology

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Daming Zhou et al.

Summary: The race to develop vaccines against SARS-CoV-2 variants, such as B.1.1.7, B.1.351, and P.1, is ongoing as these variants have mutations in the spike protein, potentially leading to immune escape. A structure-function analysis of B.1.351 revealed tighter ACE2 binding and widespread evasion from monoclonal antibody neutralization, particularly driven by the E484K mutation.
Article Multidisciplinary Sciences

Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2

Sabari Nath Neerukonda et al.

Summary: Pseudoviruses are valuable surrogates for highly pathogenic viruses due to their safety, stability, and scalability, with diverse platforms offering varied advantages and limitations. This study optimized and characterized an HIV-based lentiviral pseudovirus assay for screening neutralizing antibodies for SARS-CoV-2, showing consistent neutralization titers across different input ranges and high correlation with other assays' results. Overall, the lentiviral assay is simple, scalable, and suitable for various SARS-CoV-2 entry and neutralization screening assays.

PLOS ONE (2021)

Article Cell Biology

Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding

Dhiraj Mannar et al.

Summary: The newly emerged SARS-CoV-2 variants, Beta and Gamma, exhibit key mutations that enhance spike protein affinity for ACE2 receptor and promote antibody evasion. By engineering spike proteins with these mutations and conducting structural analyses, the effects of different variants were studied in terms of increased ACE2 affinity and antibody evasion.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Matthew McCallum et al.

Summary: The study identifies 41 human monoclonal antibodies that recognize the N-terminal domain of the SARS-CoV-2 spike protein and exhibit strong neutralizing activity. These antibodies inhibit cell-to-cell fusion, activate effector functions, and protect animals from virus challenge, highlighting the importance of NTD-specific neutralizing antibodies for protective immunity and vaccine development. Several SARS-CoV-2 variants with mutations in the NTD supersite suggest ongoing selective pressure on the virus.
Editorial Material Microbiology

An NTD supersite of attack

Shee-Mei Lok

Summary: Recent studies have identified highly protective antibodies specific to the N-terminal domain (NTD) of the SARS-CoV-2 spike protein, targeting a conserved supersite.

CELL HOST & MICROBE (2021)

Letter Infectious Diseases

SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity

Muthukumar Ramanathan et al.

LANCET INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies

Xing Zhu et al.

Summary: The UK variant of SARS-CoV-2 with the N501Y mutation shows increased infectivity due to tighter binding with the ACE2 receptor, but without significant structural changes. Important neutralization epitopes in the spike receptor binding domain are retained.

PLOS BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion

Mohd Zulkifli Salleh et al.

Summary: The emergence of SARS-CoV-2 has posed significant challenges worldwide, resulting in millions of deaths. Mutations in the spike (S) glycoprotein may impact vaccine efficacy. Variants such as Alpha, Beta, Gamma have mutations in their spike proteins that enhance viral fitness.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Biochemistry & Molecular Biology

Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function

Tzu-Jing Yang et al.

Summary: The spike protein of the SARS-CoV-2 B.1.1.7 variant exhibits mutations that affect virus binding to the host ACE2 receptor and immune evasion. The A570D and N501Y mutations have been shown to impact the stability of the spike protein structure, and an introduced neutralizing antibody can effectively neutralize different strains of the virus.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)

Article Multidisciplinary Sciences

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity

Sophie M-C Gobeil et al.

Summary: SARS-CoV-2 variants with multiple spike mutations have increased transmission and resistance to antibodies. Research showed that these variants have enhanced receptor binding and a preference for receptor binding domain up states. Different variants exhibit different mechanisms for resistance to neutralizing antibodies, which helps explain their transmission and resistance.

SCIENCE (2021)

Article Multidisciplinary Sciences

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants

Yongfei Cai et al.

Summary: The study found that the B.1.1.7 variant has increased receptor binding affinity, while the B.1.351 variant has developed resistance to some neutralizing antibodies by reshaping antigenic surfaces on the spike protein.

SCIENCE (2021)

Article Multidisciplinary Sciences

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes

Dapeng Sun et al.

Summary: Highly potent neutralizing nanobodies (Nbs) targeting the receptor binding domain (RBD) of the SARS-CoV-2 spike protein show effectiveness against circulating variants of concern. Structural analysis of the Nbs provides insights into their high-affinity and broadly neutralizing activity against the virus.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Molecular Architecture of the SARS-CoV-2 Virus

Hangping Yao et al.

Article Biochemistry & Molecular Biology

High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models

Wei Li et al.

Article Multidisciplinary Sciences

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu et al.

NATURE (2020)

Article Multidisciplinary Sciences

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

Ching-Lin Hsieh et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Structures and distributions of SARS-CoV-2 spike proteins on intact virions

Zunlong Ke et al.

NATURE (2020)

Article Multidisciplinary Sciences

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

M. Alejandra Tortorici et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Lizhou Zhang et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection

Wei Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Biochemistry & Molecular Biology

UCSF ChimeraX: Meeting modern challenges in visualization and analysis

Thomas D. Goddard et al.

PROTEIN SCIENCE (2018)

Article Biochemical Research Methods

New tools for the analysis and validation of cryo-EM maps and atomic models

Pavel V. Afonine et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2018)

Editorial Material Infectious Diseases

GISAID: Global initiative on sharing all influenza data - from vision to reality

Yuelong Shu et al.

EUROSURVEILLANCE (2017)

Article Biochemical Research Methods

cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination

Ali Punjani et al.

NATURE METHODS (2017)

Article Multidisciplinary Sciences

Data, disease and diplomacy: GISAID's innovative contribution to global health

Stefan Elbe et al.

GLOBAL CHALLENGES (2017)

Article Biochemical Research Methods

High resolution single particle refinement in EMAN2.1

James M. Bell et al.

METHODS (2016)

Article Biochemical Research Methods

MolProbity: all-atom structure validation for macromolecular crystallography

Vincent B. Chen et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)

Article Biochemical Research Methods

Features and development of Coot

P. Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Chemistry, Multidisciplinary

UCSF chimera - A visualization system for exploratory research and analysis

EF Pettersen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)